Personalized ultrafractionated stereotactic adaptive radiotherapy

PROCEDURE2 trials

Sponsors

Jonsson Comprehensive Cancer Center, Fujian Cancer Hospital

Conditions

Colorectal Cancer Liver MetastasisHead and Neck CarcinomaLocalized Head and Neck CarcinomaMetastatic Head and Neck CarcinomaRecurrent Head and Neck Carcinoma

Phase 2

PULSAR Combined With PD-1 Ab and Chemotherapy Plus Bev. for CRLM

Not yet recruitingNCT06788171

Fujian Cancer HospitalColorectal Cancer Liver Metastasis

Start: 2025-03-01End: 2026-12-01Target: 35Updated: 2025-01-23

Unknown Phase

Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy for Palliative Head and Neck Cancer Treatment (PULS-Pal)

RecruitingNCT06572423

Jonsson Comprehensive Cancer CenterHead and Neck Carcinoma, Localized Head and Neck Carcinoma, Metastatic Head and Neck Carcinoma +1

Start: 2024-10-25End: 2029-12-16Target: 43Updated: 2026-02-05

Related Papers

A phase II study of personalized ultrafractionated stereotactic adaptive radiotherapy for palliative head and neck cancer treatment (PULS-Pal): a single-arm clinical trial protocol.

2024-12-213 citations